Gemcitabine and epirubicin in patients toxicity epirubicin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Cell Line, Tumor

Diseases20

Breast Neoplasms Pancreatic Neoplasms Neutropenia Biliary Tract Neoplasms Adenocarcinoma Neoplasm Metastasis Lung Neoplasms Leukopenia Hematologic Diseases Alopecia Nausea Carcinoma, Non-Small-Cell Lung Vomiting Stomatitis Disease Progression Neoplasms Stomach Neoplasms Neoplasm Recurrence, Local Urinary Bladder Neoplasms Carcinoma, Transitional Cell

Chemicals and Drugs26

Epirubicin Deoxycytidine Antimetabolites, Antineoplastic Antibiotics, Antineoplastic Fluorouracil Cyclophosphamide Paclitaxel Taxoids Cisplatin Vinblastine Razoxane Doxorubicin Deoxycytidine Kinase Anthracyclines Antineoplastic Agents Granulocyte Colony-Stimulating Factor Carboplatin Methotrexate Ifosfamide Prolyl Hydroxylases Organoplatinum Compounds Antineoplastic Agents, Phytogenic Etoposide Equilibrative Nucleoside Transporter 1 Receptor, erbB-2 Naphthacenes

Analytical, Diagnostic and Therapeutic Techniques and Equipment19

Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Treatment Outcome Infusions, Intravenous Chemotherapy, Adjuvant Disease-Free Survival Neoadjuvant Therapy Survival Rate Maximum Tolerated Dose Neoplasm Staging Combined Modality Therapy Toxicity Tests Survival Analysis Kaplan-Meier Estimate Follow-Up Studies Injections, Intravenous Toxicity Tests, Acute Drug Evaluation Area Under Curve

Phenomena and Processes6

Dose-Response Relationship, Drug Maximum Tolerated Dose Drug Resistance, Neoplasm Drug Synergism Time Factors Area Under Curve

Information Science1

Health Care7

Treatment Outcome Disease-Free Survival Survival Rate Survival Analysis Kaplan-Meier Estimate Follow-Up Studies Area Under Curve

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care

Epirubicin Deoxycytidine Antineoplastic Combined Chemotherapy Protocols Antimetabolites, Antineoplastic Antibiotics, Antineoplastic Fluorouracil Drug Administration Schedule Cyclophosphamide Breast Neoplasms Paclitaxel Taxoids Cisplatin Pancreatic Neoplasms Treatment Outcome Infusions, Intravenous Chemotherapy, Adjuvant Vinblastine Disease-Free Survival Dose-Response Relationship, Drug Razoxane Doxorubicin Neutropenia Biliary Tract Neoplasms Neoadjuvant Therapy Deoxycytidine Kinase Survival Rate Anthracyclines Adenocarcinoma Maximum Tolerated Dose Antineoplastic Agents Granulocyte Colony-Stimulating Factor Neoplasm Metastasis Lung Neoplasms Drug Resistance, Neoplasm Neoplasm Staging Combined Modality Therapy Leukopenia Carboplatin Hematologic Diseases Toxicity Tests Methotrexate Alopecia Nausea Ifosfamide Survival Analysis Cell Line, Tumor Carcinoma, Non-Small-Cell Lung Vomiting Drug Synergism Prolyl Hydroxylases Stomatitis Organoplatinum Compounds Antineoplastic Agents, Phytogenic Disease Progression Etoposide Neoplasms Stomach Neoplasms Equilibrative Nucleoside Transporter 1 Neoplasm Recurrence, Local Urinary Bladder Neoplasms Receptor, erbB-2 Time Factors Carcinoma, Transitional Cell Naphthacenes Kaplan-Meier Estimate Follow-Up Studies Injections, Intravenous Toxicity Tests, Acute Drug Evaluation Area Under Curve

No FAQ available that match "gemcitabine and epirubicin in patients toxicity epirubicin"